DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Chesney J, Puzanov I, Collichio F. et al.
Randomized, Open-Label Phase II Study Evaluating the Efficacy and Safety of Talimogene Laherparepvec in Combination With Ipilimumab Versus Ipilimumab Alone in Patients With Advanced, Unresectable Melanoma.
J Clin Oncol 2018;
36: 1658-1667
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.